Aurora City Council has approved a major residential expansion within the Fitzsimons Innovation Community, unlocking the potential for up to 7266 new housing units across the 184-acre campus. The development will support the area’s growing life sciences hub, which is anchored by the CU Anschutz Medical Campus, and includes plans for mixed-use zones, residential-only areas,…
Researchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center (MECCC) and Utrecht University have found the first direct evidence that common respiratory infections, including COVID-19 and influenza, can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors. The findings were published…
Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing to find cures for autoimmune diseases.
As we continue our celebration of the first labs opening at Fitzsimons Innovation Community 25 years ago, few people have witnessed the campus evolution as intimately as City of Aurora Mayor Mike Coffman. His unique perspective spans decades, from childhood memories of a bustling military base to leading the city he grew up in as it embraces a booming future for bioscience innovation, patient care, and research.
Fitzsimons Innovation Community CEO Kelly Brough joined business experts Ryan Frazier and Ed Sealover on the set of 9News to chat about current growth, how Fitzsimons leverages campus assets to attract new companies to Colorado, benefits from being in an enterprise zone and opportunity zone, and is softening the edges of campus to become part…
Colorado Real Estate Journal features perspectives from Fitzsimons Innovation Community CEO, Kelly Jean Brough, in the Health Care and Life Sciences Quarterly. The article highlights 25 years of impact and what’s next for the transformation of the campus.
Fitzsimons Innovation Community, a thriving hub where researchers, practitioners, educators, and innovators collaborate to bring life-changing healthcare solutions to patients, announced the appointment of Kenneth Ho as chief operating officer. A highly respected real estate developer with more than 25 years of experience, Ho will play a pivotal role in bringing the Community’s ambitious Master…
A real estate developer with more than 25 years of experience has been appointed as the new chief operating officer of the Fitzsimons Innovation Community in Aurora. Kenneth Ho, the new COO, will play a pivotal role in bringing the community’s master plan to life. Ho has over two decades of experience in real estate…
Fitzsimons Innovation Community, a thriving hub where researchers, practitioners, educators, and innovators collaborate to bring life-changing healthcare solutions to patients, announces the appointment of Kenneth Ho as Chief Operating Officer. A highly respected real estate developer with more than 25 years of experience, Ho will play a pivotal role in bringing the Community’s ambitious Master Plan to life.
GelSana Therapeutics, Inc. has been selected to join the 2025 MedTech Innovator cohort, the world’s largest accelerator for medical device companies. GelSana is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program. This recognition reflects the incredible work of our team and validates the potential of our…